FDA OKs Novartis AG (NVS) Drug for a Form of Childhood Arthritis
5/13/2013
More...
|
FDA Approves GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Drug for COPD Lung Disease
5/13/2013
More...
|
GlaxoSmithKline (GSK)'s BREO™ ELLIPTA™ Receives Regulatory Approval in U.S.
5/13/2013
More...
|
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia
4/26/2013
More...
|
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive
4/23/2013
More...
|
European Commission (EC) Gives Green Light to New 6-in-1 Childhood Vaccine From Sanofi Pasteur (SASY.PA)
4/23/2013
More...
|
Sun Pharmaceutical Industries Ltd Gets FDA Nod for Generic Version of Januvia
4/16/2013
More...
|
BioAlliance Pharma's Sitavig® Receives Market Authorization in the U.S. for the Treatment of Herpes Labialis
4/16/2013
More...
|
Warner Chilcott, PLC (WCRX) Receives FDA Approval of DORYX Delayed-Release 200 Mg Tablets
4/12/2013
More...
|
FDA Approves Duchesnay's Diclegis for Morning Sickness
4/9/2013
More...
|
Genzyme Corporation (GENZ)'s AUBAGIO® Approved in Argentina for MS
4/8/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval for Oral Contraceptive
4/2/2013
More...
|
Astellas Pharma Inc. (YPH.BE)'s Acofide Approved in Japan
3/29/2013
More...
|
Bayer AG (BAY.F)'s Colorectal Cancer Drug Stivarga Bags Approval in Japan
3/26/2013
More...
|
Pfizer Inc. (PFE)'s XELJANZ Receives Approval in Japan
3/25/2013
More...
|
Genmab A/S (GEN.CO) and GlaxoSmithKline (GSK)'s Arzerra Receives Approval in Japan
3/25/2013
More...
|
Novartis AG (NVS)' TOBI Podhaler Gets FDA Approval
3/25/2013
More...
|
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Type I Gaucher Disease Drug Uplyso Gets Brazilian Approval
3/19/2013
More...
|
Novartis AG (NVS) Says Alcon, Inc. (ACL)'s Eye Drug Jetrea Gets EU Approval
3/18/2013
More...
|
EU Approves Roche (RHHBY)'s Perjeta to Treat Metastatic Breast Cancer
3/6/2013
More...
|
Novartis AG (NVS)'s Ilaris Cleared for Gouty Arthritis in EU
3/1/2013
More...
|
Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO) Wins Approval for Monthly Abilify Shot
3/1/2013
More...
|
Lundbeck Inc. (LUN.CO) Given EU Nod for Alcohol Dependence Drug
2/28/2013
More...
|
Novozymes Biopharma's rAlbumin Approved in Japan as MAQUET Expands Into New Market
2/28/2013
More...
|
FDA Approves Shionogi, Inc.'s Drug for Painful Intercourse in Women
2/27/2013
More...
|
FDA Approves Genentech (RHHBY)'s Drug for Late-Stage Metastatic Breast Cancer
2/26/2013
More...
|
Pfizer Inc. (PFE) Gains China Approval of Drug for Kinase-Specific Lung Cancer
2/26/2013
More...
|
Lupin Ltd. (LUPN.BO) Receives FDA Nod for Suprax Oral Suspension
2/22/2013
More...
|
Aurobindo Pharma Gets FDA Nod for Anti-Diabetes Drug
2/15/2013
More...
|
Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos
2/15/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic Adderall XR®
2/15/2013
More...
|
Celgene Corporation (CELG) Gains SFDA Approval for Multiple Myeloma Treatment
2/13/2013
More...
|
Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil"
2/7/2013
More...
|
FDA OKs Warner Chilcott, PLC (WCRX)'s Ulcerative Colitis Product
2/6/2013
More...
|
Sanofi (France) (SAN.PA) Says Zaltrap Approved in Europe for Bowel Cancer
2/5/2013
More...
|
Sanofi (France) (SAN.PA)'s Diabetes Drug Lyxumia Approved in Europe
2/4/2013
More...
|
FDA Approves 3 New Diabetes Drugs From Takeda Pharmaceutical Co. Ltd. (TKPYY)
1/29/2013
More...
|
FDA Approves Novartis AG (NVS)'s Exjade in Patients With Genetic Blood Disorder
1/24/2013
More...
|
Meda AB (MEDA-A.ST)'s Dymista Approved in Europe
1/24/2013
More...
|
Lupin Ltd. (LUPN.BO) Gets U.S. Nod for 7th Oral Contraceptive
1/23/2013
More...
|
Novartis AG (NVS) Wins EU Backing for First Meningitis B Vaccine
1/22/2013
More...
|
Novo Nordisk A/S (NVO) Gets Green Light for Tresiba in EU
1/22/2013
More...
|
ThromboGenics NV (TBGNF), Novartis AG (NVS) Win EU OK for Jetrea Eye Drug
1/21/2013
More...
|
EU Approves Johnson & Johnson (JNJ)'s Single Pill Prezista for HIV
1/16/2013
More...
|
Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
1/11/2013
More...
|
FDA Approves Roche (RHHBY)'s Tamiflu for Infants
12/27/2012
More...
|
Novo Nordisk A/S (NVO) Gains as Japan Approves Ryzodeg
12/27/2012
More...
|
UCB, Inc. (UCBJF.PK) Gets Japan Clearance for Two New Drugs
12/27/2012
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis Approved in Japan
12/27/2012
More...
|
Biotest AG Receives FDA Approval for BIVIGAM to Treat Primary Humoral Immunodeficiency
12/26/2012
More...
|
BioAlliance Pharma Announces the Registration of Sitavig® in European Countries
12/21/2012
More...
|
FDA Approves GlaxoSmithKline (GSK) Drug for Treatment of Anthrax
12/18/2012
More...
|
FDA Approves GlaxoSmithKline (GSK)'s Four-Strain Seasonal Influenza Vaccine for Use in the U.S.
12/17/2012
More...
|
Roche (RHHBY) Wins EU Backing for Perjeta Breast Cancer Drug
12/14/2012
More...
|
European Commission (EC) Clears Wider Use for Genzyme Corporation (GENZ) Cancer Treatment
12/7/2012
More...
|
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) GH Receives Ghana Food and Drug Board Packaging and Insert Approvals for Paracetamol Tablets
12/6/2012
More...
|
Trimedica Limited: European Commission (EC) Approves New Xaluprine Formulation
12/5/2012
More...
|
AstraZeneca PLC (AZN) Heart Drug Wins Approval in China
11/30/2012
More...
|
Almirall, Ironwood Pharmaceuticals Drug for IBS Gets Regulatory Approval in Europe
11/28/2012
More...
|
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) Approval From Food & Drugs Board Ghana for Anti-Malarial Pharmaceutical Gloderp® in Final Stages
11/28/2012
More...
|
Bayer AG (BAY.F)'s Eylea Gets Green Light in Europe for Wet AMD
11/27/2012
More...
|
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ)'s Once-Daily, Oral Aubagio Approved in Australia to Treat MS
11/26/2012
More...
|
FDA Approves Novel Novartis AG (NVS) Seasonal Flu Vaccine
11/26/2012
More...
|
All Wales Strategic Medical Group Approves Zebinix Anti-Epileptic Treatment
11/26/2012
More...
|
GlaxoSmithKline (GSK) Receives FDA OK for PROMACTA
11/23/2012
More...
|
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE) Anticlot Drug Gets Key EU Approval
11/23/2012
More...
|
EU OKs Bristol-Myers Squibb Company (BMY)-AstraZeneca PLC (AZN) Diabetes Drug After U.S. Rejection
11/16/2012
More...
|
Syngenta Corporation Secures EU Approval For Next Generation Fungicide
11/13/2012
More...
|
European Commission (EC) OKs uniQure's First High-Price Gene Therapy for Rare Disease
11/2/2012
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Announces SFDA Approval for Ulcer Drug
11/2/2012
More...
|
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Leukemia Drug
10/30/2012
More...
|
Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY) Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes
10/26/2012
More...
|
Novartis AG (NVS) Drug Certican® Approved by European Health Authorities to Prevent Organ Rejection in Adult Liver Transplant Patients
10/25/2012
More...
|
ViroPharma Incorporated (VPHM) Release: Health Canada Approves New Drug Submission for Cinryze™ (C1 Inhibitor [Human])
10/22/2012
More...
|
Scil Proteins GmbH Obtains European Medicines Agency Approval for Commercial Production of Reteplase
10/22/2012
More...
|
FDA: ThromboGenics NV (TBGNF) Main Drug Cleared for U.S. Launch
10/18/2012
More...
|
Bayer AG (BAY.F)'s Contraceptive Flexyess Gets EU Approval
10/10/2012
More...
|
InterMune, Inc. (ITMN) Release: Health Canada Approves Esbriet® as First Treatment for Fatal Lung Disease
10/3/2012
More...
|
Novartis AG (NVS)'s Smokers' Cough Treatment Gets European Nod
10/1/2012
More...
|
Johnson & Johnson (JNJ)'s Janssen-Cilag International NV (JNJ) Gets EC Approval for DACOGEN in AML
10/1/2012
More...
|
Astex Pharmaceuticals (ASTX) Says EU OKs Marketing for its Leukemia Drug
9/28/2012
More...
|
Janssen-Cilag International NV (JNJ)'s Subcutaneous VELCADE® Approved in the EU for the Treatment of Multiple Myeloma
9/28/2012
More...
|
Novo Nordisk A/S (NVO) Says Diabetes Drug Approved in Japan
9/28/2012
More...
|
Protalix Biotherapeutics, Inc. (PLX) Receives Marketing Authorization for Elelyso™ for the Treatment of Gaucher Disease From the Israeli Ministry of Health
9/27/2012
More...
|
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Wins FDA Approval for Multiple Sclerosis Pill
9/14/2012
More...
|
Sucampo Pharma, Ltd Gets U.K. Approval for AMITIZA in Chronic Idiopathic Constipation
9/12/2012
More...
|
Eisai Company, Ltd. (ESALY.PK) Receives Approval to Market Anticancer Agent Halaven® in Australia
9/10/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Release: Revestive® (teduglutide) Receives European Marketing Authorization for the Treatment of Adults With Short Bowel Syndrome (SBS)
9/4/2012
More...
|
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Copycat of Amgen (AMGN)'s Neupogen
8/31/2012
More...
|
FDA OKs Novartis AG (NVS)'s Afinitor Disperz for Child Brain Tumors
8/30/2012
More...
|
AstraZeneca PLC (AZN) Granted Marketing Authorisation in Europe for ZINFORO
8/28/2012
More...
|
Lundbeck Inc. (LUN.CO) Says Cancer Drug Approved in Canada
8/28/2012
More...
|
European Commission (EC) Approves Meda AB (MEDA-A.ST)'s Zyclara
8/27/2012
More...
|
FDA Clears New Flu Vaccine for Production by 6 Manufacturers, Companies Include GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA)
8/15/2012
More...
|
FDA OKs Sanofi (France) (SAN.PA)'s Auvi-Q for Patients With Life-Threatening Allergic Reactions
8/13/2012
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Release; Fanapt™ is Granted Market Approval in Israel for the Treatment of Schizophrenia
8/9/2012
More...
|
Strides Arcolab Limited Gets FDA Nod for Generic Anti-Cancer Drug
8/9/2012
More...
|
Novartis AG (NVS) Drug Afinitor Gets EU Nod for Breast Cancer
7/30/2012
More...
|
Abbott Laboratories (ABT)'s HUMIRA® Approved in Europe for Treatment of Non-radiographic Axial Spondyloarthritis (nr-axSpA)
7/30/2012
More...
|
EU Approves Vertex Pharmaceuticals Incorporated (VRTX)'s KALYDECO for Cystic Fibrosis
7/27/2012
More...
|
Eisai Inc. (ESALF.PK) Gets Approval for Anti-seizure Drug
7/27/2012
More...
|
EU OK for Almirall's COPD Drug Eklira Genuair
7/27/2012
More...
|
FDA Approves Forest Laboratories, Inc. (FRX)' Tudorza Pressair
7/25/2012
More...
|
Skyepharma PLC (SKYEF)'s Asthma Drug Gets European Marketing Nod
7/5/2012
More...
|
Sucampo Pharmaceuticals, Inc., Abbott Laboratories (ABT) Announce Approval for AMITIZA® in Japan
7/5/2012
More...
|
Eisai Company, Ltd. (ESALY.PK) Receives European Medicines Agency Approval to Market Zonegran Monotherapy for Treatment of Epilepsy
7/3/2012
More...
|
Lupin Ltd. (LUPN.BO) Receives FDA Approval for Generic Ortho Tri-cyclen Lo® Tablets
7/3/2012
More...
|
Eisai Company, Ltd. (ESALY.PK) and Toyama Chemical Company Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan
6/29/2012
More...
|
Ipsen's Somatuline Gets Marketing Approval in Japan
6/29/2012
More...
|
AMAG Pharmaceuticals, Inc. (AMAG), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Gets European Approval, $15 Million Milestone Payment
6/25/2012
More...
|
FDA Approves GlaxoSmithKline (GSK)'s Meningitis Vaccine for Children
6/18/2012
More...
|
Orexo AB Reports Regulatory Approval of Edluar® in Europe
6/18/2012
More...
|
MEDA: Edluar Approved in Europe
6/15/2012
More...
|
FDA OKs Roche (RHHBY)'s New Breast Cancer Drug
6/13/2012
More...
|
GlaxoSmithKline (GSK) and XenoPort, Inc. (XNPT) Receive FDA Approval for Horizant® for Postherpetic Neuralgia
6/7/2012
More...
|
Lupin Pharmaceuticals, Inc. Receives FDA Approval for SUPRAX® (Cefixime) Capsules, 400 Mg
6/5/2012
More...
|
Novo Nordisk A/S (NVO) Diabetes Drug Gets FDA Nod for Toddlers
5/23/2012
More...
|
Baxter International, Inc. (BAX) Announces ADVATE Approval in China for the Treatment of Hemophilia A
5/16/2012
More...
|
Clinigen Gains FDA Approval for Foscavir in HIV/AIDS-related Cytomegalovirus Infections and Herpes
5/8/2012
More...
|
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Wins FDA Nod for Gaucher Disease Drug; Genzyme Corporation (GENZ) Faces Competition
5/2/2012
More...
|
MEDA's Dymista Approved by the FDA
5/2/2012
More...
|
FDA Approves GlaxoSmithKline (GSK)'s Votrient® for Deadly Sarcomas
4/27/2012
More...
|
Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease
4/25/2012
More...
|
Ikaria Inc.'s LUCASSIN® Approved in Australia
4/24/2012
More...
|
Pfizer Inc. (PFE) Receives New UK Approval for Inspra
4/5/2012
More...
|
UCB, Inc. (UCBJF.PK)'s Neupro® Approved by FDA for Parkinson's Disease and Restless Legs Syndrome
4/4/2012
More...
|
FDA Approves Affymax, Inc. (AFFY)'s Omontys to Treat Anemia in Patients on Dialysis
3/29/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Gets FDA Approval for "Dry" Allergy Aerosol QNASL
3/27/2012
More...
|
FDA Approves First Generic Versions of Roche (RHHBY)'s Boniva
3/21/2012
More...
|
Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA(R) for the Acute Treatment of Migraine
3/20/2012
More...
|
Meda AB (MEDA-A.ST) Release: Astepro Approved in Europe
3/20/2012
More...
|
ULURU Inc. Announces Approval to Market Altrazeal® in New Zealand
3/20/2012
More...
|
Zhejiang Hisoar Pharmaceutical (SHE) Given Japanese Approval for Antibiotic
3/19/2012
More...
|
Merck Serono Fertility Treatment Pergoveris® Receives Marketing Approval in Russia
3/16/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Wins Approval for First Generic Lexapro for Depression; Awarded 180-Day Period of Marketing Exclusivity
3/15/2012
More...
|
South Korea to Approve Pfizer Inc. (PFE)'s Viagra Generics
3/15/2012
More...
|
FDA Approves EffRx's BINOSTO®, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
3/14/2012
More...
|
Teva Respiratory Receives FDA Approval for ProAir® HFA (albuterol sulfate) With Dose Counter
3/8/2012
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare (BAY) Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
3/8/2012
More...
|
AstraZeneca PLC (AZN)'s Nasal Flu Vaccine Approved In U.S.
3/1/2012
More...
|
APR Applied Pharma Research S.A. and Labtec GmbH Announce the European Approval of Zolmitriptan Oral Dispersible Film (ODF)
3/1/2012
More...
|
Forest Laboratories, Inc. (FRX) Receives European Marketing Approval for Colobreathe® Dry Powder Inhaler
2/24/2012
More...
|
AstraZeneca PLC (AZN)'s Thyroid Cancer Drug Caprelsa Gets EU Approval
2/21/2012
More...
|
BioSante Pharmaceuticals, Inc. (BPAX), Teva Pharmaceutical Industries Limited (TEVA) Surge as FDA OKs Testosterone Gel
2/16/2012
More...
|
FDA Approves Novartis Corporation (NVS)'s Gleevec for Expanded Use in Patients With Rare Gastrointestinal Cancer
2/1/2012
More...
|
FDA Approves Amylin Pharmaceuticals, Inc. (AMLN) and Alkermes plc (ALKS)'s BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes
1/30/2012
More...
|
Bayer AG (BAY.F) Gets EU Approval for Gadovist For Children Aged 2-6 Years
1/30/2012
More...
|
Green Cross Gains Market Approval With the World's 2nd Orphan Drug for Hunter Syndrome in South Korea
1/27/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Wins FDA Approval for New Way to Adminster Velcade to Patients
1/25/2012
More...
|
Eisai Company, Ltd. (ESALY.PK) Receives Approval to Market Insomnia Treatment Lunesta in Japan
1/19/2012
More...
|
Teijin Pharma's Bonalon Bag for I.V. Infusion 900 µg Approved as Japan's First I.V. Drug for Osteoporosis
1/18/2012
More...
|
Xiamen Innovax Biotech Gains Approval for Hepatitis E Vaccine
1/17/2012
More...
|
China Approves Hepatitis E Vaccine From Xiamen University and Xiamen Innovax Biotech Co. Ltd.
1/11/2012
More...
|
United Therapeutics Corporation (UTHR) Release: Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
12/28/2011
More...
|
Jiangsu Hengrui Medicine Co. Ltd. Gains FDA Approval for Cancer Drug
12/20/2011
More...
|
Roche (RHHBY) Melanoma Drug Wins European Green Light
12/19/2011
More...
|
Bayer HealthCare (BAY)'s Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in Non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis
12/19/2011
More...
|
Eisai Company, Ltd. (ESALY.PK) Announces Canadian Approval of its Anticancer Agent Halaven
12/15/2011
More...
|
Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN)'s ONGLYZA® (saxagliptin) Approved for Use in Europe as Combination Therapy With Insulin (With or Without Metformin) in Adults With Type 2 Diabetes
11/29/2011
More...
|
Novartis AG (NVS) Gets European OK for Blood Pressure Pill
11/29/2011
More...
|
Celgene International Sárl (CELG)'s REVLIMID(R) Granted Swissmedic Approval for Treatment of Rare Blood Cancer
11/23/2011
More...
|
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
11/18/2011
More...
|
Pfizer Inc. (PFE)'s Vyndaqel(R) (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
11/17/2011
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Gets Approval for First Drug from an Indian Pharma
11/3/2011
More...
|
Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Cardizem CD(R)
10/31/2011
More...
|
Eli Lilly and Company (LLY) Release: ALIMTA First Chemotherapy Approved in Europe as Continuation Maintenance Therapy for Most Common Form of Lung Cancer
10/28/2011
More...
|
Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis
10/26/2011
More...
|
Valeant Pharmaceuticals International (VRX) Announces Approval of Colesevelam Hydrochloride in Canada
9/28/2011
More...
|
Novartis AG (NVS) Receives Approval in Japan for Two Innovative Therapies, Gilenya(R) in MS and Ilaris(R) in CAPS
9/27/2011
More...
|
EU Grants Approval for Expanded Use of Roche (RHHBY)'s Tarceva
9/2/2011
More...
|
Simcere Pharmaceutical Group's Iremod Receives SFDA New Drug Approval
8/25/2011
More...
|
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Release: Trajenta® (linagliptin) Receives Approval for the Treatment of Type 2 Diabetes in Europe
8/25/2011
More...
|
Bayer Corporation (BAY) Rival Boehringer Ingelheim Corporation Gets EU Nod for Pradaxa Pill
8/8/2011
More...
|
AstraZeneca PLC (AZN) Nexium-Aspirin Combo Gets EU OK
8/2/2011
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Receives Conditional Approval in the European Union for FAMPYRA(R) to Improve Walking in Adults with Multiple Sclerosis
7/26/2011
More...
|
Bristol-Myers Squibb Company (BMY) Melanoma Drug Yervoy Gets EU Approval
7/15/2011
More...
|
Dr. Reddy's Laboratories, Inc. (RDY)'s Announces the FDA Approval of Fondaparinux Sodium Injection
7/13/2011
More...
|
FDA Approves Archimedes Pharma's Lazanda(R) - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
7/1/2011
More...
|
Merck & Co., Inc. (MRK) Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
7/1/2011
More...
|
Singapore Health Sciences Authority Approves Emergent BioSolutions (EBS) Anthrax Vaccine, BioThrax
6/24/2011
More...
|
ProStrakan Group Receives FDA Approval for Rectiv(TM) for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures
6/22/2011
More...
|
RHEI Pharmaceuticals, Inc. Gaining on SFDA Approval of MuGard(TM)
6/17/2011
More...
|
Celgene (CELG) Gets FDA OK to Expand Use of Lymphoma Drug
6/17/2011
More...
|
Almirall and GW Pharmaceuticals Release: Sativex(R) Approved in Denmark for the Treatment of Spasticity Due to Multiple Sclerosis (MS)
6/8/2011
More...
|
Almirall and GW Pharmaceuticals Release: Sativex(R) Approved in Germany for the Treatment of Spasticity Due to Multiple Sclerosis
5/26/2011
More...
|
Tianyin Pharmaceutical Co, Inc. Receives SFDA Approval for Its Anti-Diabetic Drug Gliclazide
5/13/2011
More...
|
Beijing Second Pharmaceutical Wins US Approval for Anti- Hypertensive
5/4/2011
More...
|
India Sun Pharmaceutical Industries Ltd Unit Gets U.S. Nod for Cancer Drug
5/4/2011
More...
|
BTG plc (BGC.L): ZYTIGA(TM) (abiraterone acetate) Approved in the US
5/3/2011
More...
|
Daiichi Sankyo, Inc. (D4S.F) Receives First Market Approval in Japan for LIXIANA(R) (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
4/22/2011
More...
|
Eisai Company, Ltd. (ESALY.PK): Halaven(R) Receives Approval in Japan for the Treatment of Inoperable and Recurrent Breast Cancer
4/22/2011
More...
|
Abbott Japan and Eisai Company, Ltd. (ESALY.PK) Receive Approval to Market the Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancrelipase) in Japan
4/22/2011
More...
|
GW Pharmaceuticals Release: Sativex(R) Approved in the Czech Republic
4/15/2011
More...
|
Suven Life Sciences Ltd's Unit-III Receives US FDA Acceptance
4/5/2011
More...
|
GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX) Receive EU Marketing Authorization for Seizure Drug
3/31/2011
More...
|
MediGene AG (MDGEF.PK) Announces Approval of Veregen(R) in Spain
3/30/2011
More...
|
GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX) Receive European Authorisation for Trobalt (retigabine)
3/29/2011
More...
|
curasan AG (DX:CUR): Novel Bone Regeneration Material Approved for Sale in Europe
3/28/2011
More...
|
GW Pharmaceuticals's Sativex® Mutual Recognition Procedure Closes with Recommendation for Approval in all Six European Countries Involved
3/22/2011
More...
|
Novartis AG (NVS) Receives EU Approval for Gilenya
3/21/2011
More...
|